Compare TTC & CRL Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
| Metric | TTC | CRL |
|---|---|---|
| Founded | 1914 | 1947 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Tools/Hardware | Biotechnology: Commercial Physical & Biological Resarch |
| Sector | Consumer Discretionary | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 8.8B | 8.0B |
| IPO Year | N/A | 2000 |
| Metric | TTC | CRL |
|---|---|---|
| Price | $89.94 | $217.91 |
| Analyst Decision | Buy | Buy |
| Analyst Count | 4 | 13 |
| Target Price | $90.75 | ★ $205.27 |
| AVG Volume (30 Days) | ★ 936.2K | 642.7K |
| Earning Date | 03-05-2026 | 02-18-2026 |
| Dividend Yield | ★ 1.72% | N/A |
| EPS Growth | N/A | ★ N/A |
| EPS | ★ 3.17 | N/A |
| Revenue | ★ $4,510,400,000.00 | $4,023,704,000.00 |
| Revenue This Year | $4.25 | N/A |
| Revenue Next Year | $4.64 | $1.70 |
| P/E Ratio | $28.55 | ★ N/A |
| Revenue Growth | N/A | ★ N/A |
| 52 Week Low | $62.34 | $91.86 |
| 52 Week High | $90.49 | $228.88 |
| Indicator | TTC | CRL |
|---|---|---|
| Relative Strength Index (RSI) | 72.00 | 59.48 |
| Support Level | $87.69 | $216.03 |
| Resistance Level | $90.19 | $228.39 |
| Average True Range (ATR) | 1.87 | 8.10 |
| MACD | 0.08 | -0.41 |
| Stochastic Oscillator | 94.21 | 69.84 |
The Toro Co designs, manufactures, markets, and sells professional turf maintenance equipment and services; turf and agricultural irrigation systems; landscaping equipment and lighting products; snow and ice management equipment; construction equipment; and residential yard and snow thrower products. The company operates through Professional and Residential segments, with the Professional segment serving commercial, agricultural, and construction customers and generating the majority of revenue, while the Residential segment focuses on homeowners. Its products are sold through distributors, dealers, retailers, rental centers, and direct channels, with the United States as its primary revenue-generating market.
Charles River Laboratories was founded in 1947 and is a leading provider of drug discovery and development services. The company's research model & services segment is the leading provider of animal models for laboratory testing, which breeds and delivers animal research models with specific genetic characteristics for preclinical studies around the world. The discovery & safety assessment segment includes services required to take a drug through the early development process, including discovery services. The manufacturing support segment includes microbial solutions, which provides in vitro (non-animal) testing products, biologics testing services, and avian vaccine services.